141 related articles for article (PubMed ID: 1432917)
1. FDA regulation of OTC oral health care drug products.
Rippere JL
J Public Health Dent; 1992; 52(6):329-32. PubMed ID: 1432917
[TBL] [Abstract][Full Text] [Related]
2. Legal and regulatory developments of the 1990s in oral care products: learning from what has come before.
O'Reilly JT
J Public Health Dent; 1992; 52(6):396-400. PubMed ID: 1432936
[TBL] [Abstract][Full Text] [Related]
3. Status of certain additional over-the-counter drug category II and III active ingredients--FDA. Final rule.
Fed Regist; 1998 Apr; 63(77):19799-802. PubMed ID: 10179316
[TBL] [Abstract][Full Text] [Related]
4. How the FDA and the ADA affect development of prescription drugs for oral care.
Cooley WE
J Public Health Dent; 1992; 52(6):350-2. PubMed ID: 1432922
[TBL] [Abstract][Full Text] [Related]
5. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 May; 67(90):31123-5. PubMed ID: 12001971
[TBL] [Abstract][Full Text] [Related]
6. FDA warning targets OTC chelation products.
Voelker R
JAMA; 2010 Nov; 304(19):2112. PubMed ID: 21081718
[No Abstract] [Full Text] [Related]
7. Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.
Fed Regist; 1999 Aug; 64(158):44653-8. PubMed ID: 10558603
[TBL] [Abstract][Full Text] [Related]
8. Food and Drug Administration Review and Action on Over-the-Counter Time and Extent Applications. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2016 Nov; 81(226):84465-77. PubMed ID: 27906534
[TBL] [Abstract][Full Text] [Related]
9. Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 Jan; 64(19):4535-40. PubMed ID: 10557608
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the safety and efficacy of over-the-counter oral hygiene products for the reduction and control of plaque and gingivitis.
Wu CD; Savitt ED
Periodontol 2000; 2002; 28():91-105. PubMed ID: 12013351
[No Abstract] [Full Text] [Related]
11. An overview of over the counter drugs in pregnancy and lactation.
Das BP; Joshi M; Pant CR
Kathmandu Univ Med J (KUMJ); 2006; 4(4):545-51. PubMed ID: 18603972
[TBL] [Abstract][Full Text] [Related]
12. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
Ostroff C; Lee CE; McMeekin J
Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
[TBL] [Abstract][Full Text] [Related]
13. Over-the-counter medications and self-care.
Lowe NK; Ryan-Wenger NM
Nurse Pract; 1999 Dec; 24(12):34-44. PubMed ID: 10635517
[TBL] [Abstract][Full Text] [Related]
14. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 May; 67(90):31125-7. PubMed ID: 12001972
[TBL] [Abstract][Full Text] [Related]
15. The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study.
Nguyen NT; Cook DM; Bero LA
Clin Ther; 2006 Aug; 28(8):1231-1243. PubMed ID: 16982301
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic drug products for over-the-counter human use; proposed amendment of final monograph--FDA. Proposed rule.
Fed Regist; 1998 Feb; 63(35):8888-90. PubMed ID: 10177740
[TBL] [Abstract][Full Text] [Related]
17. Advisory committees; OTC Drugs Advisory Committee; establishment--FDA. Final rule.
Fed Regist; 1991 Sep; 56(185):48103-4. PubMed ID: 10114368
[TBL] [Abstract][Full Text] [Related]
18. Child-resistant packaging for certain over-the-counter drug products. Final rule.
Consumer Product Safety Commission
Fed Regist; 2001 Aug; 66(149):40111-6. PubMed ID: 11732555
[TBL] [Abstract][Full Text] [Related]
19. Ingrown toenail relief drug products for over-the-counter human use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 May; 68(88):24347-9. PubMed ID: 12737160
[TBL] [Abstract][Full Text] [Related]
20. Oral health during cancer treatment.
J Am Dent Assoc; 2011 Jul; 142(7):877. PubMed ID: 21719812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
